Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
How AI will transform cancer care.
Ann Oncol. 2024 Sep 15:S0923-7534(24)03915-2. doi: 10.1016/j.annonc.2024.08.2335. Online ahead of print.
Ann Oncol. 2024.
PMID: 39288845
No abstract available.
Subcutaneous versus intravenous nivolumab for renal cell carcinoma.
Albiges L, Bourlon MT, Chacón M, Cutuli HJ, Chuken YAL, Żurawski B, Mota JM, Magri I, Burotto M, Luz M, de Menezes J, Ruiz EPY, Fu S, Richardet M, Valderrama BP, Maruzzo M, Bracarda S, Breckenridge M, Vezina HE, Rathod D, Yu Z, Zhao Y, Dixon M, Perumal D, George S.
Albiges L, et al.
Ann Oncol. 2024 Sep 15:S0923-7534(24)03996-6. doi: 10.1016/j.annonc.2024.09.002. Online ahead of print.
Ann Oncol. 2024.
PMID: 39288844
Free article.
Item in Clipboard
Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study.
Lu S, Ahn MJ, Reungwetwattana T, Özgüroğlu M, Kato T, Yang JC, Huang M, Fujiki F, Inoue T, Quang LV, Sriuranpong V, Vicente D, Fuentes C, Chaudhry AA, Poole L, Armenteros Monterroso E, Rukazenkov Y, van der Gronde T, Ramalingam SS.
Lu S, et al.
Ann Oncol. 2024 Sep 11:S0923-7534(24)03823-7. doi: 10.1016/j.annonc.2024.08.2243. Online ahead of print.
Ann Oncol. 2024.
PMID: 39289145
Free article.
Item in Clipboard
Cite
Cite